Please login to the form below

Not currently logged in
Email:
Password:

AZD0914

This page shows the latest AZD0914 news and features for those working in and with pharma, biotech and healthcare.

Cubist antibiotic to get priority review in US

Cubist antibiotic to get priority review in US

It is the second boost for new antibiotics in the US this month after the FDA's decision to grant fast track status to AstraZeneca's AZD0914 for the sexually transmitted

Latest news

  • FDA fast-tracks new AstraZeneca antibiotic FDA fast-tracks new AstraZeneca antibiotic

    FDA fast-tracks new AstraZeneca antibiotic. Speeds up review period for AZD0914 in gonorrhoea. ... AZD0914 has shown promise as a treatment for the sexually transmitted infection (STI) uncomplicated gonorrhoea, which, like other infectious diseases, is

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
FCB Halesway

A Eureka moment! A converted dairy in the Hampshire countryside back in 1993 saw the inception of Halesway as a...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics